22272 ⎘
Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action; Inhibitors, antagonists of receptors
Non-cellular root canal filler and non-cellular dental tissue regeneration promotion kit
#2Drug-Coated Balloon Controllable In Drug Metabolism And Preparation Method Therefor
#3Improved Lyophilized Formulations Involving Hyaluronic Acid and Plasmatic Proteins, and Uses Thereof
#4Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
#5COMPOSITIONS AND METHODS TO PROMOTE WOUND HEALING
#6Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
#7Extracellular Matrices, Uses thereof, and Method for Making Extracellular Matrices
#8Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
#9Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
#10COMPOSITIONS AND METHODS OF IMPROVED WOUND HEALING
#11Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
#12Controlled and precise treatment of cardiac tissues
#13SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR TREATING OCULAR VASCULOPATHIES
#14Targeted Treatment Of Anerobic Cancer
#15ANTAGONISTS OF CHEMOKINE RECEPTORS
#16Hyaluronic acid-based hydrogels having medical applications
#17Compositions and methods of improved wound healing
#18Compositions and methods to promote wound healing
#19PHARMACEUTICAL COMPOSITIONS AND DEVICE METHODS FOR TREATMENT OF PROLIFERATIVE DISEASES
#20Pharmacological therapy for neuronopathic Gaucher disease
#21Compositions and methods for treating and preventing neointimal stenosis
#22Targeted treatment of anerobic cancer
#23TISSUE REPAIR DEVICES AND SCAFFOLDS
#24DEVICES, SYSTEMS, AND METHODS FOR SPG BLOCK AND NEURO-MODULATION
#25COMBINATION THERAPY TO PROMOTE WOUND HEALING
#26Sustained release intraocular implants and methods for treating ocular vasculopathies
#27Biocompatible polymer compositions for tissue void filling
#28PAR-1 activation by metalloproteinase-1 (MMP-1)
#29Steroid-containing sustained release intraocular implants and related methods
#30Antagonists of chemokine receptors
#31Method Of Treating Vascular Lesions
#32DEVICES, COMPOSITIONS AND METHODS UTILIZING EP4 AND EP2 RECEPTOR AGONISTS FOR PREVENTING, REDUCING OR TREATING CAPSULAR CONTRACTURE
#33METHODS AND APPARATUS FOR TREATMENT OF ANEURYSMAL TISSUE
#34LOCAL VASCULAR DELIVERY OF ADENOSINE A2A RECEPTOR AGONISTS IN COMBINATION WITH OTHER AGENTS TO REDUCE MYOCARDIAL INJURY
#35Methods of treating ocular disease using steroid-containing sustained release intraocular implants
#36PAR-1 Activation by Metalloproteinase-1 (MMP-1)
#37TREATMENT FOR INTIMAL HYPERPLASIA AND RELATED CONDITIONS
#38Methods of wound care and treatment
#39Use of Histamine H4 antagonist for the treatment of post-operative adhesions
#40DISC AUGMENTATION WITH HYALURONIC ACID
#41Method for Control of Drug Elution Rate and Composition for Coating of Drug-Eluting Stent
#42EGFR inhibitors promote axon regeneration
#43COATING STENTS WITH CYCLIC RGD PEPTIDES OR MIMETICS
#44METHODS FOR REDUCING NEOVASCULARIZATION OR EDEMA
#45EGFR inhibitors promote axon regeneration
#46Sustained release intraocular implants and methods for treating ocular vasculopathies
#47Sustained release intraocular implants and methods for treating ocular vasculopathies
#48Sustained release intraocular implants and methods for treating ocular vasculopathies
#49METHOD OF COATING STENT WITH GLYCOPROTEIN RECEPTOR INHIBITOR
#50Inhibition of Calcification on an Endovascular Device
#51Medical devices to treat or inhibit restenosis
#52Steroid-containing sustained release intraocular implants and related methods
#53EGFR inhibitors promote axon regeneration
#54Polymer coating for medical devices
#55Use of organic compounds
#56Intraocular implants and methods for improving vision
#57Sustained release intraocular implants and methods for treating ocular vasculopathies
#58Medical devices to treat or inhibit restenosis
#59Medical devices to treat or inhibit restenosis
#60Medical devices to treat or inhibit restenosis
#61Combination drug therapy for reducing scar tissue formation
#62Retinoid receptor pan-antagonists for stimulating chondrogenesis